Alpha Cure Therapeutics is developing precision safe (non-radioactive) radioligand therapy via small molecule next-generation BNCT. We aim to cure Breast Cancer including Triple Negative Breast Cancer (+other indications)

Our platform does for radiopharma what small molecules did for antibodies/peptides, unlocking high value intracellular targets combining pathway inhibition with neutron-activated α-particles

Alpha Cure Therapeutics

Scott L Cohen

This department focuses on high-level organizational direction, decision-making, and overall strategic initiatives.

Alpha Cure Therapeutics

Org chart

Teams

Leadership and Strategy

Offices

Alpha Cure Therapeutics

Org chart

Teams

Leadership and Strategy

Offices

Related companies